Second Malignancies in Children and Adolescents With Extracranial Germ Cell Tumors: A Report From the Malignant Germ Cell Tumor International Consortium
Whilst men with testicular cancer have a twofold increase in second malignant neoplasms (SMNs), the risk in children with germ cell tumors (GCTs) is not fully quantified. SMNs in children treated for GCTs was assessed in the Malignant Germ Cell Tumor International Consortium data commons (n = 917). Thirteen SMNs were identified with median follow-up of only 5.9 years. Assigning cause is nuanced because GCT-related SMNs can either be treatment related, second primary malignancies from a common primordial germ cell progenitor, or somatic malignant transformation of the original GCT. Longer follow-up of children with GCT is needed to ascertain risk and understand causation.
Authors
- Michelle Nuño
- Sara Stoneham (ORCID: https://orcid.org/0000-0001-5482-648X)
- Brice Fresneau (ORCID: https://orcid.org/0000-0001-7603-7828)
- M. Krailo
- Negar Fallahazad
- Priya Mahajan
- A. Lindsay Frazier
Institutions
- Children's Oncology Group (CH)
- University of Southern California (US)
- Inserm (FR)
- Université de Versailles Saint-Quentin-en-Yvelines (FR)
- Université Paris-Saclay (FR)
- Institut Gustave Roussy (FR)
- Centre de recherche en Epidémiologie et Santé des Populations (FR)
- Seattle Children's Hospital (US)
- Children's Oncology Group (US)
- Children with Cancer UK (GB)
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center (US)
- University College London (GB)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2026-03-15
- DOI
- https://doi.org/10.1002/1545-5017.70206
- Primary Topic
- Testicular diseases and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00